Table 3.
Plasma creatine kinase (CK) activity and the incidence of necrosis in Control and simvastatin-treated animals
| Animal | Treatment | CK (IU l−1) | Necrosisa |
|---|---|---|---|
| 1 | Control | 170 | — |
| 2 | Control | 127 | — |
| 3 | Control | 149 | — |
| 4 | Control | 91 | * |
| 5 | Control | 211 | * |
| 6 | Control | 169 | — |
| 7 | Day 4, 80 mg | 168 | — |
| 8 | Day 4, 80 mg | 340 | — |
| 9 | Day 4, 80 mg | 497 | — |
| 10 | Day 4, 80 mg | 151 | — |
| 11 | Day 4, 80 mg | 504 | — |
| 12 | Day 4, 80 mg | 136 | — |
| 13 | Day 12, 80 mg | 189 | — |
| 14 | Day 12, 80 mg | 194 | — |
| 15 | Day 12, 80 mg | 161 | — |
| 16 | Day 12, 80 mg | 11 756 | ** |
| 17 | Day 12, 80 mg | 540 | ** |
| 18 | Day 12, 88 mg | 32 140 | ** |
| 19 | Day 12, 88 mg | 358 | ** |
| 20 | Day 12, 88 mg | 128 010 | * |
| 21 | Day 12, 88 mg | 32 500 | ** |
Incidence of necrosis: —, none;
minimal (up to 10 single fibres affected);
mild (up to 20% of fibres in section affected).